Citeer als: (2022, november) Hyperthermia induced by transient receptor potential vanilloid-1 (TRPV1) antagonists in human clinical trials: Insights from mathematical modeling and meta-analysis. https://geertdevuyst.be/publicatie/2020-garami-hyperthermia-induced-by-transient-receptor-potential-vanilloid-1-trpv1-antagonists-in-human-clinical-trials/
Hyperthermia induced by transient receptor potential vanilloid-1 (TRPV1) antagonists in human clinical trials: Insights from mathematical modeling and meta-analysis
Artikel Engels Opgeleid
TitelHyperthermia induced by transient receptor potential vanilloid-1 (TRPV1) antagonists in human clinical trials: Insights from mathematical modeling and meta-analysisAuteur(s)Garami, A., Shimansky, Y. P., Rumbus, Z., Vizin, R. C. L., Farkas, N., Hegyi, J., Szakacs, Z., Solymar, M., Csenkey, A., Chiche, D. A., Kapil, R., Kyle, D. J., Van Horn, W. D., Hegyi, P., & Romanovsky, A. A.PublicatiePharmacology & TherapeuticsVolume208Publicatiejaar2020Pagina’s107474DOIhttps://doi.org/10.1016/j.pha ... UitgeverElsevier BVCiteer alsGarami, A., Shimansky, Y. P., Rumbus, Z., Vizin, R. C. L., Farkas, N., Hegyi, J., Szakacs, Z., Solymar, M., Csenkey, A., Chiche, D. A., Kapil, R., Kyle, D. J., Van Horn, W. D., Hegyi, P., & Romanovsky, A. A. (2020). Hyperthermia induced by transient receptor potential vanilloid‑1 (TRPV1) antagonists in human clinical trials: Insights from mathematical modeling and meta‑analysis. Pharmacology & Therapeutics, 208, 107474. https://doi.org/10.1016/j.pharmthera.2020.107474